NCT01690520 arm group 9dfb050b6cdd89911f9aaf059006a2eb [clinicaltrials_resource:NCT01690520/arm-group/9dfb050b6cdd89911f9aaf059006a2eb]
Double-Unit Umbilical Cord Blood Transplantation [clinicaltrials_resource:10786ed00064bd2ec601734a9e3a6692]Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion [clinicaltrials_resource:714838d309d252d9913f79618dbd7e19]Cyclosporine [clinicaltrials_resource:74f6b13487a273618a612202cc6fde3e]Fludarabine Phosphate [clinicaltrials_resource:84c61d84515f8963db01f014d74b8379]Mycophenolate Mofetil [clinicaltrials_resource:859726bd4c12dda931fa6fb83f32bf3d]Cyclophosphamide [clinicaltrials_resource:897796ecd1ccbb9948874b92b409303f]Total-Body Irradiation [clinicaltrials_resource:d003c2708f533e3fa03f04a992598002]Laboratory Biomarker Analysis [clinicaltrials_resource:f647685cc96e0d62e7c222cab94a14f9]Umbilical Cord Blood Transplantation [clinicaltrials_resource:faea3c91d80ad0af7bb3d10871b18ffd]Donor Umbilical Cord Blood Transplant With or Without Ex-Vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes [clinicaltrials:NCT01690520]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01690520 arm group 9dfb050b6cdd89911f9aaf059006a2eb [clinicaltrials_resource:NCT01690520/arm-group/9dfb050b6cdd89911f9aaf059006a2eb]
Bio2RDF identifier
NCT01690520/arm-group/9dfb050b6cdd89911f9aaf059006a2eb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... fb050b6cdd89911f9aaf059006a2eb
description [clinicaltrials_vocabulary:description]
CONDITIONING REGIMEN: Patients ...... PO as in Standard of Care Arm.
identifier
clinicaltrials_resource:NCT01690520/arm-group/9dfb050b6cdd89911f9aaf059006a2eb
title
NCT01690520 arm group 9dfb050b6cdd89911f9aaf059006a2eb
@en
type
label
NCT01690520 arm group 9dfb050b ...... b050b6cdd89911f9aaf059006a2eb]
@en